Maravai LifeSciences reports Q4 2024 earnings results

Maravai LifeSciences Holdings, Inc. held its fourth-quarter earnings conference call on March 20, 2025. The company discussed its financial results for 2024 and had key executives present. Deb Hart, the Head of Investor Relations, opened the call and welcomed everyone. She noted that slides related to the earnings call are available on the company’s website. After her introduction, Trey Martin, the CEO, and Kevin Herde, the CFO, shared their insights on the company's performance over the past year. During the call, management provided forward-looking statements about the company’s future. They also discussed both GAAP and non-GAAP financial measures. These details are important for understanding the company's financial health and may differ from what was expected. Hart reminded participants that actual results could vary from the forecasts shared in the meeting. Attendees who have questions were encouraged to ask after the formal presentation. Overall, the call aimed to inform investors about Maravai's current standing and future outlook.